684 related articles for article (PubMed ID: 31409289)
41. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
[TBL] [Abstract][Full Text] [Related]
42. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.
Alvarez-Uria G; Pakam R; Midde M; Naik PK
J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123
[TBL] [Abstract][Full Text] [Related]
43. The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting.
Houben RM; Glynn JR; Mboma S; Mzemba T; Mwaungulu NJ; Mwaungulu L; Mwenibabu M; Mpunga J; French N; Crampin AC
AIDS; 2012 Nov; 26(17):2233-9. PubMed ID: 22951633
[TBL] [Abstract][Full Text] [Related]
44. High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011-2017.
Phyo KH; Oo MM; Harries AD; Saw S; Aung TK; Moe J; Thuya SS; Mon YY; Min AC; Naing NN; Kyi MS; Aung ST; Oo HN
Int J Tuberc Lung Dis; 2019 Mar; 23(3):349-357. PubMed ID: 30871667
[TBL] [Abstract][Full Text] [Related]
45. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.
Lawn SD; Kranzer K; Edwards DJ; McNally M; Bekker LG; Wood R
AIDS; 2010 Jun; 24(9):1323-8. PubMed ID: 20386425
[TBL] [Abstract][Full Text] [Related]
46. Tuberculosis and its association with CD4
Geremew D; Melku M; Endalamaw A; Woldu B; Fasil A; Negash M; Baynes HW; Geremew H; Teklu T; Deressa T; Tessema B; Sack U
BMC Infect Dis; 2020 May; 20(1):325. PubMed ID: 32380957
[TBL] [Abstract][Full Text] [Related]
47. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
[TBL] [Abstract][Full Text] [Related]
48. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy.
Suwanpimolkul G; Gatechompol S; Kawkitinarong K; Ueaphongsukkit T; Sophonphan J; Siriyakorn N; Jirajariyavej S; Khusuwan S; Panarat P; Wannalerdsakun S; Saetiew N; Chayangsu S; Wiwatrojanagul S; Noopetch P; Danpornprasert P; Mekviwattanawong S; Fujitnirun C; Lertpiriyasuwat C; Han WM; Kerr SJ; Ruxrungtham K; Avihingsanon A;
J Int AIDS Soc; 2022 Apr; 25(4):e25900. PubMed ID: 35384317
[TBL] [Abstract][Full Text] [Related]
49. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
Golub JE; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; King BS; Efron A; Moore RD; Chaisson RE; Durovni B
AIDS; 2007 Jul; 21(11):1441-8. PubMed ID: 17589190
[TBL] [Abstract][Full Text] [Related]
50. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
51. Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland.
Gupta RK; Rice B; Brown AE; Thomas HL; Zenner D; Anderson L; Pedrazzoli D; Pozniak A; Abubakar I; Delpech V; Lipman M
Lancet HIV; 2015 Jun; 2(6):e243-51. PubMed ID: 26423197
[TBL] [Abstract][Full Text] [Related]
52. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
Kassa A; Teka A; Shewaamare A; Jerene D
Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
[TBL] [Abstract][Full Text] [Related]
53. Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
Gupta-Wright A; Wood R; Bekker LG; Lawn SD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):261-70. PubMed ID: 23846570
[TBL] [Abstract][Full Text] [Related]
54. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study.
Ahmed A; Mekonnen D; Shiferaw AM; Belayneh F; Yenit MK
BMJ Open; 2018 Feb; 8(2):e016961. PubMed ID: 29437750
[TBL] [Abstract][Full Text] [Related]
55. Pattern of linkage and retention in HIV care continuum among patients attending referral HIV care clinic in private sector in India.
Parchure R; Kulkarni V; Kulkarni S; Gangakhedkar R
AIDS Care; 2015; 27(6):716-22. PubMed ID: 25559639
[TBL] [Abstract][Full Text] [Related]
56. Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.
Kazibwe A; Oryokot B; Mugenyi L; Kagimu D; Oluka AI; Kato D; Ouma S; Tayebwakushaba E; Odoi C; Kakumba K; Opito R; Mafabi CG; Ochwo M; Nkabala R; Tusiimire W; Kateeba Tusiime A; Alinga SB; Miya Y; Etukoit MB; Biraro IA; Kirenga B
PLoS One; 2022; 17(5):e0266285. PubMed ID: 35576223
[TBL] [Abstract][Full Text] [Related]
57. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
[TBL] [Abstract][Full Text] [Related]
58. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
59. Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.
Said K; Verver S; Kalingonji A; Lwilla F; Mkopi A; Charalambous S; Reither K
Afr Health Sci; 2017 Mar; 17(1):208-215. PubMed ID: 29026395
[TBL] [Abstract][Full Text] [Related]
60. The tuberculosis challenge in a rural South African HIV programme.
Houlihan CF; Mutevedzi PC; Lessells RJ; Cooke GS; Tanser FC; Newell ML
BMC Infect Dis; 2010 Feb; 10():23. PubMed ID: 20146818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
